Halo Sign and Improved Outcome | Zendy

Paul E. Verweij | Zendy; L. van Die | Zendy; J. Peter Donnelly | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Halo Sign and Improved Outcome

Author(s) -

Paul E. Verweij,

L. van Die,

J. Peter Donnelly

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/518387

Subject(s) - medicine , sign (mathematics) , halo sign , outcome (game theory) , surgery , computed tomography , mathematical analysis , mathematics , mathematical economics

A (n p 67) 42 25 37.9 17.5 33 (49.3) 53 (79.1) B (n p 100) 61 39 31.6 18.2 36 (36.0) 80 (80.0) chronic hepatitis B in China. Clin Infect Dis 2007; 44:541–8. 5. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 2004; 72:363–9. 6. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000; 33:998–1002. 7. Cooksley WG, Piratvisuth T, Lee SD, et al. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J Viral Hepat 2003; 10: 298–305. 8. Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006; 355:2444–51.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research